Damon Runyon Dale F. Frey Award

The Damon Runyon Dale F. Frey Award is administered by the Damon Runyon Cancer Research Foundation, a private philanthropic organization dedicated to supporting innovative cancer research and fostering the next generation of scientific leaders. The award specifically targets a highly selective group of prior Damon Runyon Fellows and Quantitative Biology Fellows, recognizing exceptional early-career scientists who have already demonstrated significant promise in cancer research. By limiting eligibility to individuals previously funded through its fellowship programs, the foundation ensures that applicants have undergone rigorous prior vetting and have a proven track record of research productivity and leadership potential. The purpose of the award is to support the continued development of outstanding postdoctoral researchers as they transition toward independent careers in cancer research. The program emphasizes both scientific achievement and forward-looking vision, requiring applicants to articulate not only their past accomplishments but also their long-term research trajectory and its potential impact on the field. The award is designed to bridge the gap between fellowship training and independent funding, enabling recipients to sustain momentum in their research programs and pursue innovative, high-risk ideas that may not yet qualify for traditional funding mechanisms. While specific funding amounts and allowable cost categories are not detailed in the provided material, the award is structured to begin immediately following the completion of the recipient’s Damon Runyon Fellowship. For fellows whose appointments have already concluded, the award offers a defined start date of January 1, 2027. This timing flexibility ensures continuity in research activities and minimizes disruptions during a critical career transition period. There is no indication of cost-sharing or matching requirements, suggesting that the award is intended to provide direct support without additional financial obligations from recipients or their institutions. Eligibility is narrowly defined and restricted to specific cohorts of Damon Runyon Fellows and Quantitative Biology Fellows selected during designated cycles. This exclusivity reflects the foundation’s strategy of investing deeply in a curated pipeline of researchers. Applicants must have been selected in November 2022, May 2023, or February 2024 under specified fellowship identifiers. As a result, the program does not accept open applications from the general public or broader academic community, but instead operates as an internal advancement opportunity for a predefined group of scientists. The application process is conducted through Proposal Central and requires submission by a firm deadline of July 15, 2026 at 4:00 PM Eastern Time. Applicants must prepare a comprehensive but concise set of materials, including a two-page research summary covering past accomplishments, future vision, and career goals. Additional required components include a biosketch following NIH guidelines, a full bibliography with hyperlinks, documentation of professional activities, and a list of ongoing research support. Two reference letters are mandatory and must be submitted by the deadline, with strict requirements regarding the qualifications and independence of referees. Applications cannot be submitted until all reference materials are complete. The evaluation process includes an initial review leading to the selection of a small number of finalists, who are notified in October 2026. These finalists participate in interviews with members of the Fellowship Award Committee in November 2026. This multi-stage review process highlights the competitive nature of the award and the importance of both written application materials and personal presentation. Final funding decisions are made following the interview stage, with award activation aligned to fellowship completion timelines. Key dates for the program include the application deadline of July 15, 2026, finalist notification in October 2026, and finalist interviews on November 5, 2026. The program appears to operate on a recurring annual cycle, tied to the progression of Damon Runyon Fellows. Applicants are advised to maintain updated contact information with the foundation and to coordinate closely with referees to ensure timely submission of required materials. For inquiries, the foundation provides a centralized contact email and general organizational contact information, reinforcing its structured and professional administration of the award process.

Ensure clarity and conciseness in the two page research summary emphasize long term impact on cancer research and align career goals with independent research trajectory